2026-04-14T15:13:57Zhttps://uvadoc.uva.es/oai/request

oai:uvadoc.uva.es:10324/85962021-09-23T07:53:22Zcom_10324_1133com_10324_931com_10324_894col_10324_1209

Benzodiazepine use and risk of dementia: prospective population based study Billiot ide Gage, Sophie Bégaud, Bernard Bazin, Fabienne Verdoux, Hélène Dartigues, Jean-François Pérès, Karine Kurth, Tobias Pariente, Antoine Carvajal García-Pando, Alfonso Benzodiazepinas Producción Científica Objective To evaluate the association between use of benzodiazepines and incident dementia. Design Prospective, population based study. Setting PAQUID study, France. Participants 1063 men and women (mean age 78.2 years) who were free of dementia and did not start taking benzodiazepines until at least the third year of follow-up. Main outcome measures Incident dementia, confirmed by a neurologist. Results During a 15 year follow-up, 253 incident cases of dementia were confirmed. New use of benzodiazepines was associated with an increased risk of dementia (multivariable adjusted hazard ratio 1.60, 95% confidence interval 1.08 to 2.38). Sensitivity analysis considering the existence of depressive symptoms showed a similar association (hazard ratio 1.62, 1.08 to 2.43). A secondary analysis pooled cohorts of participants who started benzodiazepines during follow-up and evaluated the association with incident dementia. The pooled hazard ratio across the five cohorts of new benzodiazepine users was 1.46 (1.10 to 1.94). Results of a complementary nested case-control study showed that ever use of benzodiazepines was associated with an approximately 50% increase in the risk of dementia (adjusted odds ratio 1.55, 1.24 to 1.95) compared with never users. The results were similar in past users (odds ratio 1.56, 1.23 to 1.98) and recent users (1.48, 0.83 to 2.63) but reached significance only for past users. Conclusions In this prospective population based study, new use of benzodiazepines was associated with increased risk of dementia. The result was robust in pooled analyses across cohorts of new users of benzodiazepines throughout the study and in a complementary case-control study. Considering the extent to which benzodiazepines are prescribed and the number of potential adverse effects of this drugclass in the general population, indiscriminate widespread use should be cautioned against. 2015-03-03T12:43:33Z 2015-03-03T12:43:33Z 2012 info:eu-repo/semantics/article BMJ 2012;345:e6231 0959-8138 http://uvadoc.uva.es/handle/10324/8596 10.1136/bmj.e6231 BMJ 345 eng info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by-nc-nd/4.0/ Attribution-NonCommercial-NoDerivatives 4.0 International BMJ Publishing Group SI